NDUFA5P7

Across TCGA pan-cancer cohorts, NDUFA5P7 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated NDUFA5P7 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher NDUFA5P7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated NDUFA5P7 expression acts as an unfavorable survival marker.

KIRC, SKCM, and BLCA are the cancer types where NDUFA5P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	II,III,IV	0.192	0.720	.002	60	view →
SKCM	DFS	Tertile	All	0.058	0.757	<.001	54	view →
BLCA	DFS	Tertile	All	0.159	0.625	.016	27	view →
STAD	OS	Tertile	II,III,IV	0.215	0.660	.019	18	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

NDUFA5P7–KIRC (OS)

Open the KIRC breakdown →